Histopathology · 2007 · 132 citations · 42 references
MedicineOncologyPathologyGastrointestinal OncologyMolecular OncologyNeoplasiaCancer BiomarkersCancer Molecular PathologyColorectal CancerMalignant NeoplasmsMolecular Tumor ProfilingWnt SignalingColorectal Cancer PrognosisE-cadherin LossImmunohistochemical BiomarkersImmunohistochemical MarkersImmunohistochemical StainingMicroarray AnalysisPrognostic Factors AnalysisTissue Microarray Analysis
AIMS: To investigate dysregulation of the wnt signalling pathway by assessing beta-catenin expression/increasing expression and loss of cytoplasmic adenomatous polyposis coli (APC) and membranous E-cadherin in colorectal cancer (CRC) and determining the prognostic significance of these variables. METHODS AND RESULTS: Unselected, non-consecutive CRC resections (n = 1420) were subdivided into three groups: mismatch repair (MMR)-proficient, MLH1- and presumed hereditary non-polyposis colonic cancer (HNPCC). Immunohistochemical analysis of beta-catenin expression (0% versus > 0%) and increasing expression (increasing percentage-positivity) and loss of APC and E-cadherin was performed using the tissue microarray technique. In MMR-proficient CRC, increased nuclear beta-catenin expression and loss of membranous E-cadherin were independently associated with higher N stage (P = 0.03 and < 0.0001), vascular invasion (P < 0.01 and < 0.001) and worse survival (P < 0.01 and < 0.001). Additionally, there was an association between loss of membranous E-cadherin and higher T stage (P = 0.03). In MLH1- CRC, loss of membranous E-cadherin was associated with higher N stage (P = 0.05) and worse survival (P = 0.03). In presumed HNPCC CRC nuclear beta-catenin and membranous E-cadherin were not associated with tumour progression or worse survival. In all CRC subsets loss of cytoplasmic APC was not associated with clinicopathological features. CONCLUSIONS: Increasing nuclear beta-catenin expression and loss of membranous E-cadherin are independent, adverse prognostic factors in MMR-proficient and MLH1- CRC.
42
Functional interaction of β-catenin with the transcription factor LEF-1
Jürgen Behrens, Jens Peter von Kries, Michael Kühl et al. · Nature · 1996 · 2.9K citations
β‐catenin is a target for the ubiquitin–proteasome pathway
Hermann Aberle, Andreas Bauer, Jörg Stappert et al. · The EMBO Journal · 1997 · 2.5K citations
Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly
Bonnee Rubinfeld, Iris Albert, Emilio Porfiri et al. · Science · 1996 · 1.4K citations